The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma.


Journal

Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617

Informations de publication

Date de publication:
17 10 2023
Historique:
received: 30 05 2023
accepted: 22 08 2023
medline: 7 11 2023
pubmed: 18 10 2023
entrez: 18 10 2023
Statut: ppublish

Résumé

Chondroitin polymerizing factor (CHPF) is an important glycosyltransferases that participates in the biosynthesis of chondroitin sulfate (CS). Our previous study showed that silencing CHPF expression inhibited glioma cell proliferation

Identifiants

pubmed: 37851364
pii: 205076
doi: 10.18632/aging.205076
pmc: PMC10637790
doi:

Substances chimiques

Chondroitin 9007-27-6
Hepatocyte Nuclear Factors 0
MAD1L1 protein, human 0
Cell Cycle Proteins 0
HNF4A protein, human 0
Hepatocyte Nuclear Factor 4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11052-11066

Références

Cell Death Dis. 2020 Jul 1;11(7):496
pubmed: 32612115
PLoS Genet. 2021 Nov 11;17(11):e1009598
pubmed: 34762652
Nat Commun. 2022 Jan 11;13(1):224
pubmed: 35017517
Org Biomol Chem. 2021 Jun 28;19(24):5312-5326
pubmed: 34048524
Cell Mol Biol Lett. 2015 Jun;20(2):196-212
pubmed: 26204402
J Cell Sci. 2012 Sep 15;125(Pt 18):4197-206
pubmed: 23093575
J Biol Chem. 2010 Oct 29;285(44):34155-67
pubmed: 20729547
J Biol Chem. 2003 Jun 27;278(26):23666-71
pubmed: 12716890
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3072-3078
pubmed: 31343368
Nucleic Acids Res. 2019 Sep 5;47(15):8096-8110
pubmed: 31291454
Int J Biochem Cell Biol. 2017 Aug;89:171-181
pubmed: 28549626
Cancers (Basel). 2021 Mar 12;13(6):
pubmed: 33809195
Oncol Rep. 2017 Aug;38(2):1149-1155
pubmed: 28627702
J Cell Sci. 2019 Jun 17;132(12):
pubmed: 31138679
Biochim Biophys Acta. 2013 Oct;1830(10):4719-33
pubmed: 23774590
Cancer J. 2021 Sep-Oct 01;27(5):410-415
pubmed: 34570456
Cancer Cell Int. 2021 Jul 13;21(1):372
pubmed: 34256750
J Cell Biol. 2019 Apr 1;218(4):1108-1117
pubmed: 30674583
Cancer Cell. 2020 Nov 9;38(5):647-660
pubmed: 32916125
Cell Cycle. 2016;15(4):493-7
pubmed: 26752263
Front Cell Dev Biol. 2021 Aug 13;9:695970
pubmed: 34490248
Cell Death Dis. 2020 Jun 11;11(6):447
pubmed: 32527996
Clin Epigenetics. 2019 Dec 30;11(1):199
pubmed: 31888761
FEBS Open Bio. 2021 Feb;11(2):423-434
pubmed: 33301643
J Biol Chem. 2008 Apr 25;283(17):11396-406
pubmed: 18316376
Histopathology. 2018 May;72(6):997-1006
pubmed: 29243296
Semin Oncol Nurs. 2018 Dec;34(5):420-429
pubmed: 30392758
Commun Biol. 2021 Jan 25;4(1):114
pubmed: 33495490
Therap Adv Gastroenterol. 2017 Oct;10(10):761-771
pubmed: 29051787
Nature. 2000 Apr 13;404(6779):725-8
pubmed: 10783877
Am J Cancer Res. 2021 Mar 01;11(3):812-826
pubmed: 33791155
EBioMedicine. 2019 Feb;40:163-175
pubmed: 30686753
Pathol Res Pract. 2019 May;215(5):988-994
pubmed: 30826152
Biomacromolecules. 2019 Aug 12;20(8):3021-3030
pubmed: 31287284
J Biol Chem. 2018 Jan 12;293(2):484-496
pubmed: 29162720
Cell Death Dis. 2021 Sep 25;12(10):876
pubmed: 34564711
Cell Death Dis. 2019 Nov 21;10(12):879
pubmed: 31754182
Neuro Oncol. 2020 Aug 17;22(8):1073-1113
pubmed: 32328653
Oncogene. 2001 May 31;20(25):3301-5
pubmed: 11423979
Braz J Med Biol Res. 2020;53(5):e9021
pubmed: 32348423
JAMA Oncol. 2020 Dec 1;6(12):1939-1946
pubmed: 33119048
Int J Clin Exp Pathol. 2017 Sep 01;10(9):9391-9399
pubmed: 31966811
Nat Commun. 2021 Feb 12;12(1):1014
pubmed: 33579922
Cancer Manag Res. 2019 Apr 24;11:3275-3283
pubmed: 31118773
Cell Cycle. 2021 Mar-Mar;20(5-6):591-602
pubmed: 33651657
J Clin Oncol. 2019 May 1;37(13):1130-1135
pubmed: 30883246
Ren Fail. 2023 Dec;45(1):2173950
pubmed: 36794657
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188353
pubmed: 32112817
Front Oncol. 2019 Mar 13;9:138
pubmed: 30918839
Aging (Albany NY). 2021 Mar 26;13(7):9911-9926
pubmed: 33795521
Genes Dev. 1990 Dec;4(12B):2353-65
pubmed: 2279702
Int J Mol Sci. 2021 Oct 18;22(20):
pubmed: 34681857

Auteurs

Haitao Luo (H)

Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi Province, China.

Kai Huang (K)

Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi Province, China.

Mengqi Cheng (M)

Department of Health Management Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.

Xiaoyan Long (X)

Science Research Center, East China Institute of Digital Medical Engineering, Shangrao, Jiangxi Province, China.

Xingen Zhu (X)

Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi Province, China.

Miaojing Wu (M)

Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.
Institute of Neuroscience, Nanchang University, Nanchang, Jiangxi Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH